HighVista Strategies’s Bioverativ Inc. Common Stock BIVV Stock Holding History

HighVista Strategies’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15,954	Closed	-$860K	–	256
2017 Q4	$860K	Sell	15,954 -19,564	-55%	-$1.07M	0.24%	88
2017 Q3	$2.03M	Sell	35,518 -624	-2%	-$36.5K	0.46%	52
2017 Q2	$2.17M	Hold	36,142	–	–	0.5%	53
2017 Q1	$1.97M	Buy	+36,142	New	+$1.78M	0.44%	53

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

HighVista Strategies's BIVV Position: Q1 2018 in Review

HighVista Strategies sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 15,954 shares — an estimated $860K sold.

HighVista Strategies first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.17M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

HighVista Strategies reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
HighVista Strategies sold 15,954 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $860K.
HighVista Strategies first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
HighVista Strategies's Bioverativ Inc. Common Stock position peaked at $2.17M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on HighVista Strategies's 13F filing for Q1 2018, filed 15 May 2018.